Michael John Sumner - Jun 30, 2022 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
Chief Medical Officer
Signature
/s/ Michael John Sumner
Stock symbol
INO
Transactions as of
Jun 30, 2022
Transactions value $
$0
Form type
4
Date filed
7/6/2022, 06:21 PM
Previous filing
Jul 6, 2022
Next filing
Feb 28, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Common Stock Options Award $0 +160K $0.00 160K Jun 30, 2022 Common Stock 160K $1.73 Direct F1
transaction INO Restricted Stock Unit Award $0 +105K $0.00 105K Jun 30, 2022 Common Stock 105K Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The vesting schedule for the 160,000 options is as follows: 40,000 shares vested on June 30, 2022; 40,000 shares will vest on June 30, 2023; 40,000 shares will vest on June 30, 2024; 40,000 shares will vest on June 30, 2025.
F2 Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 105,000 restricted stock units is as follows: 35,000 shares will vest on June 30, 2023; 35,000 shares will vest on June 30, 2024; 35,000 shares will vest on June 30, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.